Advisory Alpha LLC Sells 1,214 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Alpha LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 56.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 933 shares of the medical equipment provider's stock after selling 1,214 shares during the period. Advisory Alpha LLC's holdings in Intuitive Surgical were worth $462,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Atala Financial Inc bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $26,000. Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares during the period. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $0.11 during mid-day trading on Thursday, hitting $558.06. 1,241,906 shares of the company's stock traded hands, compared to its average volume of 1,644,331. The company's 50-day moving average is $520.78 and its two-hundred day moving average is $539.13. The company has a market capitalization of $200.02 billion, a P/E ratio of 87.06, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $405.08 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the company earned $1.50 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on ISRG shares. Evercore ISI cut their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Royal Bank of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 489 shares of the company's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares in the company, valued at $1,114,879.38. This represents a 18.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 25,716 shares of company stock valued at $12,831,288 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.